Control of self-renewal and differentiation of hematopoietic stem cells: HOXB4 on the threshold

Annals of the New York Academy of Sciences

Volumn 1044, Issue , 2005, Pages 6-15

  Klump, Hannes ^a   Schiedlmeier, Bernhard ^a   Baum, Christopher ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Dosage effects; Gene therapy; Hematopoiesis; HOX genes; HOXB4; Threshold levels

Indexed keywords

HOMEODOMAIN PROTEIN; HOMEODOMAIN TRANSCRIPTION FACTOR HOXB4; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL RENEWAL; CELL TRANSFORMATION; CONFERENCE PAPER; DOSE RESPONSE; EMBRYONIC STEM CELL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IN VITRO STUDY; IN VIVO STUDY; LABORATORY; NONHUMAN; PROTEIN EXPRESSION; SOMATIC GENE THERAPY;

EID: 22044453432     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1349.002     Document Type: Conference Paper

References (58)

1. GREER, J.M. et al. 2000. Maintenance of functional equivalence during paralogous Hox gene evolution. Nature 403: 661-665.
2. ZHAO, Y. & S.S. POTTER. 2002. Functional comparison of the Hoxa 4, Hoxa 10, and Hoxa 11 homeoboxes. Dev. Biol. 244: 21-36.
3. DUBOULE, D. 2000. Developmental genetics. A Hox by any other name. Nature 403: 607, 609-610.
4. PRADEL, J. & R.A. WHITE. 1998. From selectors to realizators. Int. J. Dev. Biol. 42: 417-421.
5. TABATA, T. & Y. TAKEI. 2004. Morphogens, their identification and regulation. Development 131: 703-712.
6. WOLPERT, L. 1969. Positional information and the spatial pattern of cellular differentiation. J. Theor. Biol. 25: 1-47.
7. DRIEVER, W. & C. NUSSLEIN-VOLHARD. 1988. The bicoid protein determines position in the Drosophila embryo in a concentration-dependent manner. Cell 54: 95-104.
8. MCGINNIS, W. & R. KRUMLAUF. 1992. Homeobox genes and axial patterning. Cell 68: 283-302.
9. HUANG, A.M., J. RUSCH & M. LEVINE. 1997. An anteroposterior Dorsal gradient in the Drosophila embryo. Genes Dev. 11: 1963-1973.
10. YAN, H. et al. 2002. Small changes in expression affect predisposition to tumorigenesis. Nat. Genet. 30: 25-26.
11. MAENO, M. et al. 1996. The role of BMP-4 and GATA-2 in the induction and differentiation of hematopoietic mesoderm in Xenopus laevis. Blood 88: 1965-7192.
12. ZON, L.I. 2001. Self-renewal versus differentiation, a job for the mighty morphogens. Nat. Immunol. 2: 142-143.
13. BHARDWAJ, G. et al. 2001. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat. Immunol. 2: 172-180.
14. SONG, W.J. et al. 1999. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat. Genet. 23: 166-175.
15. ROSENBAUER, F. et al. 2004. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU. 1. Nat. Genet. 36: 624-630.
16. FISHER, R.C. & E.W. SCOTT. 1998. Role of PU.1 in hematopoiesis. Stem Cells 16: 25-37.
17. WILSON, A. et al. 2004. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev. 18: 2747-2763.
18. EMAMBOKUS, N. et al. 2003. Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb. Embo J. 22: 4478-4488.
19. OWENS, B.M. & R.G. HAWLEY. 2002. HOX and non-HOX homeobox genes in leukemic hematopoiesis. Stem Cells 20: 364-379.
20. PINEAULT, N. et al. 2002. Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. Exp. Hematol. 30: 49-57.
21. LAWRENCE, H.J. & C. LARGMAN. 1992. Homeobox genes in normal hematopoiesis and leukemia. Blood 80: 2445-2453.
22. SAUVAGEAU, G. et al. 1994. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc. Natl. Acad. Sci. USA 91: 12223-12227.
23. ANTONCHUK, J., G. SAUVAGEAU & R.K. HUMPHRIES. 2002. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109: 39-45.
24. SAUVAGEAU, G. et al. 1995. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev. 9: 1753-1765.
25. THORSTEINSDOTTIR, U., G. SAUVAGEAU & R.K. HUMPHRIES. 1999. Enhanced in vivo regenerative potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size. Blood 94: 2605-2612.
26. BUSKE, C. & R.K. HUMPHRIES. 2000. Homeobox genes in leukemogenesis. Int. J. Hematol. 71: 301-308.
27. KLUMP, H. et al. 2001. Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategy. Gene Ther. 8: 811-817.
28. DONNELLY, M.L. et al. 1997. The cleavage activities of aphthovirus and cardiovirus 2A proteins. J. Gen. Virol. 78: 13-21.
29. DONNELLY, M.L. et al. 2001. Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip.' J. Gen. Virol. 82: 1013-1025.
30. RYAN, M., M. DONELLY, A. LEWIS, et al. 1999. A model for nonstoichiometric, cotranslational protein scission in eukaryotic ribosomes. Bioorganic Chemistry 27: 55-79.
31. PILAT, S. et al. HOXB4 enforces equivalent fates of ES-cell derived and adult hematopoietic cells. Submitted August 2004.
32. SCHIEDLMEIER, B. et al. 2003. High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation. Blood 101: 1759-1768.
33. MILSOM, M.D. et al. 2005. Overexpression of HOXB4 confers a myelo-erythroid differentiation delay in vitro. Leukemia 19: 148-153.
34. BRUN, A.C. et al. 2003. Enforced adenoviral vector-mediated expression of HOXB4 in human umbilical cord blood CD34+ cells promotes myeloid differentiation but not proliferation. Mol. Ther. 8: 618-628.
35. BRUN, A.C. et al. 2004. Hoxb4 deficient mice have normal hematopoietic development but exhibit a mild proliferation defect in hematopoietic stem cells. Blood 12: 12.
36. GRAF, T. 2002. Differentiation plasticity of hematopoietic cells. Blood 99: 3089-3101.
37. PAN, Q. & R.U. SIMPSON. 1999. c-Myc intron element-binding proteins are required for 1, 25-dihydroxyvitamin D3 regulation of c-myc during HL-60 cell differentiation and the involvement of HOXB4. J. Biol. Chem. 274: 8437-8444.
38. ZHANG, Y. et al. 2003. CUL-4A stimulates ubiquitylation and degradation of the HOXA9 homeodomain protein. Embo J. 22: 6057-6067.
39. MANN, R.S. & S.K. CHAN. 1996. Extra specificity from extradenticle: the partnership between HOX and PBX/EXD homeodomain proteins [published erratum appears in Trends Genet 1996 Aug;12(8): 328]. Trends Genet. 12: 258-262.
40. CHANG, C.P. et al. 1996. Pbx modulation of Hox homeodomain amino-terminal arms establishes different DNA-binding specificities across the Hox locus. Mol. Cell. Biol. 16: 1734-1745.
41. KROSL, J. et al. 2003. The competitive nature of HOXB4-transduced HSC is limited by PBX1: the generation of ultra-competitive stem cells retaining full differentiation potential. Immunity 18: 561-571.
42. BESLU, N. et al. 2004. Molecular interactions involved in HOXB4-induced activation of HSC self-renewal. Blood 104: 2307-2314.
43. SATOH, Y. et al. 2004. Roles for c-Myc in self-renewal of hematopoietic stem cells. J. Biol. Chem. 279: 24986-24993.
44. PAN, Q. & R.U. SIMPSON. 2001. Antisense knockout of HOXB4 blocks 1,25-dihydroxyvitamin D3 inhibition of c-myc expression. J. Endocrinol. 169: 153-159.
45. MORENO, E. & K. BASLER. 2004. dMyc transforms cells into super-competitors. Cell 117: 117-129.
46. DE LA COVA, C. et al. 2004. Drosophila myc regulates organ size by inducing cell competition. Cell 117: 107-116.
47. KONDO, M. et al. 2003. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 21: 759-806.
48. NILSSON, S.K., H.M. JOHNSTON & J.A. COVERDALE. 2001. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 97: 2293-2299.
49. ASKENASY, N. et al. 2002. Transplanted hematopoietic cells seed in clusters in recipient bone marrow in vivo. Stem Cells 20: 301-310.
50. BAUM, C. et al. 2003. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 101: 2099-2114.
51. PISLARU, S. et al. 2002. Defining gene transfer before expecting gene therapy: putting the horse before the cart. Circulation 106: 631-636.
52. WU, X. et al. 2003. Transcription start regions in the human genome are favored targets for MLV integration. Science 300: 1749-1751.
53. MITCHELL, R.S. et al. 2004. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2: E234.
54. WILLIAMS, D.A. & C. BAUM. 2003. Medicine. Gene therapy - new challenges ahead. Science 302: 400-401.
55. KROSL, J. et al. 2003. In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat. Med. 9: 1428-1432.
56. AMSELLEM, S. et al. 2003. Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nat. Med. 9: 1423-1427.
57. GALLA, M. et al. 2004. Retroviral pseudotransduction for targeted cell manipulation. Mol. Cell. 16:309-315.
58. SMITS, E. et al. 2004. RNA-based gene transfer for adult stem cells and T cells. Leukemia 18: 1898-1902.